Title : Substrate compositional variation with tissue/region and Gba1 mutations in mouse models--implications for Gaucher disease.

Pub. Date : 2013

PMID : 23520473






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Gaucher disease results from GBA1 mutations that lead to defective acid beta-glucosidase (GCase) mediated cleavage of glucosylceramide (GC) and glucosylsphingosine as well as heterogeneous manifestations in the viscera and CNS. Glucosylceramides glucosidase, beta, acid Mus musculus
2 Gaucher disease results from GBA1 mutations that lead to defective acid beta-glucosidase (GCase) mediated cleavage of glucosylceramide (GC) and glucosylsphingosine as well as heterogeneous manifestations in the viscera and CNS. Glucosylceramides glucosidase, beta, acid Mus musculus
3 Gaucher disease results from GBA1 mutations that lead to defective acid beta-glucosidase (GCase) mediated cleavage of glucosylceramide (GC) and glucosylsphingosine as well as heterogeneous manifestations in the viscera and CNS. Glucosylceramides glucosidase, beta, acid Mus musculus
4 Gaucher disease results from GBA1 mutations that lead to defective acid beta-glucosidase (GCase) mediated cleavage of glucosylceramide (GC) and glucosylsphingosine as well as heterogeneous manifestations in the viscera and CNS. Glucosylceramides glucosidase, beta, acid Mus musculus
5 Gaucher disease results from GBA1 mutations that lead to defective acid beta-glucosidase (GCase) mediated cleavage of glucosylceramide (GC) and glucosylsphingosine as well as heterogeneous manifestations in the viscera and CNS. Glucosylceramides glucosidase, beta, acid Mus musculus